Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

APOL1 Associated Kidney Disease clinical trials

1 of 1 indexed APOL1 Associated Kidney Disease trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

APOL1 Associated Kidney Disease: 1 US clinical trial tracked, 1 recruiting.

APOL1 Associated Kidney Disease is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is St. Louis University, running 1 of these trials.

Enrollment posture brief

Registry condition apol1-associated-kidney-disease

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

APOL1 Associated Kidney (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near APOL1 Associated Kidney Disease

APOL1 Associated Kidney Disease lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for APOL1 Associated Kidney Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. APOL1 Associated Kidney Disease is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on APOL1 Associated Kidney Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Assessment of the frequency of APOL-1 renal risk variant in the black population, and evaluating their attitudes about genetic testing and APOL1 genotype via self-administered surveys Genetic
1 trials

US sites by state

Facility locations filed on APOL1 Associated Kidney Disease trials. A trial with sites in several states counts in each.

Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this APOL1 Associated Kidney Disease page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 APOL1 Associated Kidney Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • St. Louis University sponsors the most APOL1 Associated Kidney Disease trials on record, review their full trial history before evaluating a specific study. See St. Louis University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This APOL1 Associated Kidney Disease condition card totals 1 registered trials; most-linked intervention Assessment of the frequency of APOL-1 renal risk variant in the black population, and evaluating their attitudes about genetic testing and APOL1 genotype via self-administered surveys; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.